Insider Transactions in Q3 2025 at Cytokinetics Inc (CYTK)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 15
2025
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
164
+0.53%
|
$6,232
$38.01 P/Share
|
|
Jul 15
2025
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
559
+0.75%
|
$21,242
$38.01 P/Share
|
|
Jul 15
2025
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
328
+1.43%
|
$12,464
$38.01 P/Share
|
|
Jul 15
2025
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
328
+1.08%
|
$12,464
$38.01 P/Share
|
|
Jul 15
2025
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
164
+0.5%
|
$6,232
$38.01 P/Share
|
|
Jul 14
2025
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.26%
|
$190,000
$38.15 P/Share
|
|
Jul 08
2025
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
2,000
-1.4%
|
$66,000
$33.76 P/Share
|
|
Jul 08
2025
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+1.38%
|
$20,000
$10.6 P/Share
|
|
Jul 01
2025
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
5,000
-1.24%
|
$165,000
$33.55 P/Share
|